RxDoctor Payments Data

Jennifer Winter, PA

Physician Assistant · Olympia, WANPI 1740280056

Payments from drug & device makers

$5,108in general payments, 2019–2025

Across 219 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Arthrex$632
  • AbbVie$583
  • E.r. Squibb & Sons, L.L.C.$443
  • Pfizer$260
  • UCB, Inc.$253
  • plus $2K from 16 others

What the payments were for

  • Travel & lodging$48810%
  • Food & beverage$4,32485%
  • Education$2956%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,108 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$268,162
Medicare patients
1,159
Services billed
3,531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa15$316,902
RinvoqUpadacitinib13$97,033
Humira(Cf) PenAdalimumab11$74,205
SiliqBrodalumab12$65,131
Cyclosporine ModifiedCyclosporine, Modified14$21,208
Doxycycline Hyclate199$5,162
Clobetasol Propionate135$4,549
Tacrolimus36$4,234
Famciclovir31$2,397
Fluorouracil37$2,345
Metronidazole34$1,918
Desonide11$1,700
Ketoconazole56$1,034
ValacyclovirValacyclovir Hcl17$698
Betamethasone Dipropionate13$696

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$583$97,03313 claims
Ortho Dermatologics, A Division Of Bausch Health US, LLCSiliq$117$65,13112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Olympia

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →